Healthcare >> CEO Interviews >> October 12, 2001

Steven Rauscher – Genome Therapeutics Corporation (gene)

STEVEN M. RAUSCHER is President and Chief Executive Officer of Oscient Pharmaceuticals Corporation. He has been a director since 1993 and joined the company full-time as President and Chief Executive Officer in 2000. Before joining Oscient Pharmaceuticals, Mr. Rauscher spent 18 years at Abbott Laboratories, serving in a variety of key leadership positions including Vice President for Corporate Licensing; Vice President of Business Development; Vice President of Sales U.S. Pharmaceutical Products Division; Director of Strategic Planning for Pharmaceutical Products; and General Manager, Abbott West Indies. Following his time at Abbott, Mr. Rauscher served as CEO of AmericasDoctor, a company that provides clinical research and marketing services to the pharmaceutical industry. Mr. Rauscher holds an MBA from the University of Chicago. Profile
TWST: We'd like to begin with a brief historical sketch and an overview

of the company.

Mr. Rauscher: Genome Therapeutics is a genomic-based biopharmaceutical

company. The company operates two